Is sentinel lymph node biopsy necessary in the setting of microinvasive DCIS?
Background: Breast cancer treatment guidelines recommend the surgeon perform a sentinel lymph node biopsy (SLNB) for patients with ductal carcinoma in situ (DCIS) who have a high risk of invasive cancer or for whom a mastectomy is planned.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: K. Desai, R. Pham, J. Shin, K. Horn, A. Harbhajanka, L. Sieck Tags: POSTERS A: Optimal Diagnosis Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Mastectomy